Other News

Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope

Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May 19, 2023 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need […]

Reflow Medical Introduces the coraCatheters™ Line and Expands into Complex Percutaneous Coronary Interventions (PCI)

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announced that it has received FDA commercial clearance for its coraCatheters™, a complete line of state-of-the-art microcatheters engineered to access and cross complex and challenging lesions in percutaneous coronary interventions. The coraCatheters family of novel devices is the latest in the Reflow portfolio, which […]

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems. The combination of Abbott’s leading cardiac mapping system with Stereotaxis’ advanced robotic technology brings together highly detailed real-time diagnostic information with […]

CorFlow Announces Positive Data from the MOCA I First in Human Study Presented at EuroPCR 2023

Novel CoFI device found to be safe and highly effective in detecting coronary microvascular obstruction (MVO) in the cathlab immediately after primary PCI PARIS–(BUSINESS WIRE)–CorFlow Therapeutics AG, a clinical-stage company that has developed the world’s first combined system for diagnostic assessment and therapy delivery to address coronary microvascular obstruction (MVO), […]

Rocket Pharmaceuticals Presents Positive Data from LV Hematology and AAV Cardiovascular Gene Therapy Programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Robust and sustained efficacy in both adult PKD patients up to 30 months post-RP-L301; first pediatric patient results suggest efficacy similar to adult cohort with initial greater than five-point increase in hemoglobin Sustained genetic correction observed in eight of 12 evaluable Fanconi Anemia patients, and phenotypic correction and concomitant hematologic […]

NEW LATE-BREAKING DATA REINFORCE THE BENEFITS OF ABBOTT’S TRICLIP™ DEVICE FOR PEOPLE WITH TRICUSPID VALVE DISEASE

Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves Findings from the largest real-world dataset for tricuspid repair show device reduces tricuspid regurgitation and improves quality of life ABBOTT PARK, Ill., May 17, 2023 — Abbott […]

Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People’s Heart Rhythms Long-Term

Abbott’s Assert-IQ offers the world’s longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott’s portfolio of connected health devices, the Assert-IQ ICM offers long-term monitoring and remote programming to improve connectivity to patients The device provides continuous monitoring for abnormal heart rhythms while offering tools […]

FDA Approves Next Generation MicroPort CRM AlizeaTM and CeleaTM Pacemaker Systems

Alizea™ and Celea™ are the world’s longest-lasting pacemakers for their size on the market today1 AlizeaTM and CeleaTM Pacemaker Systems feature AutoMRI™ Mode and Bluetooth®2 Connectivity May 18, 2023 08:00 AM Eastern Daylight Time CLAMART, France–(BUSINESS WIRE)–MicroPort CRM, a global pioneer in the field of Cardiac Rhythm Management, headquartered in France, announced today it […]